These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11812741)

  • 1. A metalloporphyrin-based superoxide dismutase mimic inhibits adoptive transfer of autoimmune diabetes by a diabetogenic T-cell clone.
    Piganelli JD; Flores SC; Cruz C; Koepp J; Batinic-Haberle I; Crapo J; Day B; Kachadourian R; Young R; Bradley B; Haskins K
    Diabetes; 2002 Feb; 51(2):347-55. PubMed ID: 11812741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nondepleting anti-CD4 has an immediate action on diabetogenic effector cells, halting their destruction of pancreatic beta cells.
    Phillips JM; Harach SZ; Parish NM; Fehervari Z; Haskins K; Cooke A
    J Immunol; 2000 Aug; 165(4):1949-55. PubMed ID: 10925277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule.
    Trembleau S; Gregori S; Penna G; Gorny I; Adorini L
    J Immunol; 2001 Oct; 167(7):4104-14. PubMed ID: 11564833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death.
    Suk K; Kim S; Kim YH; Kim KA; Chang I; Yagita H; Shong M; Lee MS
    J Immunol; 2001 Apr; 166(7):4481-9. PubMed ID: 11254704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-gamma-dependent regulatory circuits in immune inflammation highlighted in diabetes.
    Calderon B; Suri A; Pan XO; Mills JC; Unanue ER
    J Immunol; 2008 Nov; 181(10):6964-74. PubMed ID: 18981116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice.
    Tian J; Zekzer D; Hanssen L; Lu Y; Olcott A; Kaufman DL
    J Immunol; 2001 Jul; 167(2):1081-9. PubMed ID: 11441119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones. Differential requirement for CD8 T-cells.
    Peterson JD; Haskins K
    Diabetes; 1996 Mar; 45(3):328-36. PubMed ID: 8593938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells.
    Kim SK; Tarbell KV; Sanna M; Vadeboncoeur M; Warganich T; Lee M; Davis M; McDevitt HO
    Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14204-9. PubMed ID: 15381770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of NIT-1 pancreatic beta-cells from immune attack by inhibition of NF-kappaB.
    Stephens LA; Thomas HE; Kay TW
    J Autoimmun; 1997 Jun; 10(3):293-8. PubMed ID: 9218757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with soluble BDC 2.5 T cell receptor-immunoglobulin chimeric protein:antibody specificity and protection of nonobese diabetic mice against adoptive transfer of diabetes by maternal immunization.
    McKeever U; Khandekar S; Newcomb J; Naylor J; Gregory P; Brauer P; Jesson M; Bettencourt B; Burke E; Alderson A; Banerji J; Haskins K; Jones B
    J Exp Med; 1996 Nov; 184(5):1755-68. PubMed ID: 8920864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes.
    Zhang Y; Lee AS; Shameli A; Geng X; Finegood D; Santamaria P; Dutz JP
    J Immunol; 2010 May; 184(10):5645-53. PubMed ID: 20393135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mt-Nd2(a) Modifies resistance against autoimmune type 1 diabetes in NOD mice at the level of the pancreatic β-cell.
    Chen J; Gusdon AM; Piganelli J; Leiter EH; Mathews CE
    Diabetes; 2011 Jan; 60(1):355-9. PubMed ID: 20980458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of inflammatory infiltrate in activation and effector function of cloned islet reactive nonobese diabetic CD8+ T cells: involvement of a nitric oxide-dependent pathway.
    Gurlo T; Kawamura K; von Grafenstein H
    J Immunol; 1999 Dec; 163(11):5770-80. PubMed ID: 10570259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice.
    Daniel D; Gill RG; Schloot N; Wegmann D
    Eur J Immunol; 1995 Apr; 25(4):1056-62. PubMed ID: 7537670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of intercellular adhesion molecule 1 on pancreatic beta-cells accelerates beta-cell destruction by cytotoxic T-cells in murine autoimmune diabetes.
    Yagi N; Yokono K; Amano K; Nagata M; Tsukamoto K; Hasegawa Y; Yoneda R; Okamoto N; Moriyama H; Miki M
    Diabetes; 1995 Jul; 44(7):744-52. PubMed ID: 7789642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the pathogenicity of autoantigen-specific T-cell receptors.
    Burton AR; Vincent E; Arnold PY; Lennon GP; Smeltzer M; Li CS; Haskins K; Hutton J; Tisch RM; Sercarz EE; Santamaria P; Workman CJ; Vignali DA
    Diabetes; 2008 May; 57(5):1321-30. PubMed ID: 18299317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes.
    Amrani A; Verdaguer J; Thiessen S; Bou S; Santamaria P
    J Clin Invest; 2000 Feb; 105(4):459-68. PubMed ID: 10683375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice.
    Kanagawa O; Militech A; Vaupel BA
    J Immunol; 2002 Jun; 168(12):6159-64. PubMed ID: 12055228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A glutamic acid decarboxylase 65-specific Th2 cell clone immunoregulates autoimmune diabetes in nonobese diabetic mice.
    Tisch R; Wang B; Atkinson MA; Serreze DV; Friedline R
    J Immunol; 2001 Jun; 166(11):6925-36. PubMed ID: 11359854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.